 |
MorphoSys AG
MOR
|
-15.2 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Acorda Therapeutics
ACOR
|
-188 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
-6.85 |
- |
- |
$ 86.2 M |
USA |
 |
AlloVir
ALVR
|
-3.02 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Amgen
AMGN
|
26.5 |
$ 340.0 |
-0.75 % |
$ 183 B |
USA |
 |
Amneal Pharmaceuticals
AMRX
|
1.44 |
$ 12.32 |
-0.24 % |
$ 3.86 B |
USA |
 |
Applied Molecular Transport
AMTI
|
-3.2 |
- |
- |
$ 10.1 M |
USA |
 |
Applied Therapeutics
APLT
|
-0.77 |
- |
- |
$ 8.42 M |
USA |
 |
I-Mab
IMAB
|
0.08 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
-2.24 |
- |
2.54 % |
$ 160 B |
France |
 |
Arcutis Biotherapeutics
ARQT
|
-0.09 |
$ 23.27 |
-1.63 % |
$ 2.96 B |
USA |
 |
Biophytis SA
BPTS
|
-0.23 |
- |
-13.47 % |
$ 169 M |
France |
 |
Autolus Therapeutics plc
AUTL
|
-0.99 |
$ 1.36 |
-2.16 % |
$ 362 M |
Britain |
 |
AVROBIO
AVRO
|
0.24 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
-2.42 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
0.74 |
- |
- |
$ 96.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
-0.09 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
0.42 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-1.68 |
$ 3.76 |
4.35 % |
$ 9.05 B |
Australia |
 |
CymaBay Therapeutics
CBAY
|
-0.95 |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
-5.96 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aytu BioScience
AYTU
|
-0.39 |
$ 2.57 |
-3.38 % |
$ 16.1 M |
USA |
 |
Avid Bioservices
CDMO
|
-0.12 |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
-27.7 |
- |
- |
$ 1.41 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 |
- |
- |
- |
Russia |
 |
Checkpoint Therapeutics
CKPT
|
-1.42 |
- |
- |
$ 169 M |
USA |
 |
Cellectar Biosciences
CLRB
|
-8.73 |
$ 2.75 |
1.48 % |
$ 7.17 M |
USA |
 |
Aeterna Zentaris
AEZS
|
-0.08 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
-2.84 |
- |
- |
$ 231 M |
USA |
 |
AgeX Therapeutics
AGE
|
-2.35 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
-2.21 |
- |
- |
$ 401 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 |
- |
- |
$ 26.5 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
-0.68 |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
-3.89 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
0.01 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-3.85 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Cyclerion Therapeutics
CYCN
|
-1.44 |
$ 3.48 |
-16.14 % |
$ 8.76 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-2.46 |
- |
- |
$ 2.18 B |
USA |
 |
Akero Therapeutics
AKRO
|
-4.25 |
- |
- |
$ 3.67 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
-0.25 |
- |
- |
$ 2.02 B |
USA |
 |
CureVac N.V.
CVAC
|
-2.22 |
- |
- |
$ 867 M |
Germany |
 |
Dyadic International
DYAI
|
-0.2 |
$ 0.88 |
1.66 % |
$ 31.8 M |
USA |
 |
BioNTech SE
BNTX
|
62.6 |
$ 89.62 |
-1.82 % |
$ 27.2 B |
Germany |
 |
Coherus BioSciences
CHRS
|
-1.54 |
$ 1.67 |
- |
$ 196 M |
USA |
 |
Akari Therapeutics, Plc
AKTX
|
-0.67 |
$ 3.8 |
7.34 % |
$ 256 B |
Britain |
 |
Akouos
AKUS
|
-2.45 |
- |
0.23 % |
$ 488 M |
USA |
 |
Allakos
ALLK
|
-2.19 |
- |
- |
$ 28.6 M |
USA |